Total synthesis of bleomycin A21)
โ Scribed by Tomohisa Takita; Yoji Umezawa; Sei-ichi Saito; Hajime Morishima; Hiroshi Naganawa; Hamao Umezawa; Tsutomu Tsuchiya; Toshiaki Miyake; Shunji Kageyama; Sumio Umezawa; Yasuhiko Muraoka; Masanobu Suzuki; Masami Otsuka; Masatoshi Narita; Susumu Kobayashi; Masaji Ohno
- Book ID
- 104220378
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- French
- Weight
- 231 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
โฆ Synopsis
Bleomycin A2 has been synthesized for the first time.
Bleomycin (BLM) is an antitumor antibiotic clinically used in the treatment of squamous cell carcinoma, malignant lymphoma and testis tumors. BLM A2 (Q2), the major component of natural BLMs, consists of a linear hexapeptide named deglyco-BLM A2 and an 0-carbamoyl disaccharide. We have already reported the syntheses of deglyco-BLM A2 3,4) and 2-0-(a-D-mannopyranosyl)-L-gulose 5) , the disaccharide of BLM. Therefore, the total synthesis of BLM A2 is formally established by introduction of carbamoyl group to the disaccharide and glycosylation of deglyco-BLM A2 with the 0-carbamoyl disaccharide. In this communication, we report the first total synthesis of BLM.
๐ SIMILAR VOLUMES
Surmnary: Deglyco-bleomycin A2, the aglycon of bleomycin time. A2, has been synthesized for the first Bleomycin (BIM) is an antitumor antibiotic clinically used in the treatment of squamous cell carcinoma and malignant lymphoma. 1 In addition to its medicinal importance, BLM is of great interest bec
An improved route to synthesize deglyco-bleomycin A2, the aglycon of bleomycin A2, aiming at the total synthesis of bleomycin is described. The new route is characterized by the stepwise elongation of the amino acid constituents and the use of a thiol ester obtained by aldol condensation. Deglyco-b